Popularizing stem cell therapies will require the systematic, consistent production of billions of cells and carefully monitoring their production to prevent unintended side effects. Even now, growing and differentiating groups of cells for lab experiments is a process requiring close quality control. The National Institute of Standards and Technol (Read more...)